“…Although we observed minor photocytotoxic effect of aclarubicin with conjunction with LPL compared to the phototoxic effects reported previously for other anthracyclines (Brophy and Keller, 1992;Canti et al, 1998;Lanks et al, 1994;Paiva et al, 1996Paiva et al, , 1998 it seems that aclarubicin might be considered as a good candidate for combined PDT, especially as in contrast to other anthracyclines (doxorubicin, daunorubicin) it displays considerably lower cardiotoxicity (Natale et al, 1993). Aclarubicin strongly absorbs light in the long wavelength region of the visible spectra, which also theoretically makes this drug a good candidate as a photosensitizer.…”